|
Indian Pediatr 2020;57:
1191 |
 |
Spinal Muscular Atrophy Type 1 With Exon
8 Deletion and Bilateral Optic Atrophy
|
Bijaylaxmi Behera* and Ajay Kumar
Department of Pediatrics, Maulana Azad Medical College,
New Delhi, India.
Email:
[email protected]
|
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular
disease with incidence of 1 in 5-10,000 live births and is caused by
homozygous deletion of exons 7 and 8 in the SMN1 gene
[1]. Isolated exon 8 deletion has been reported in only one case series
[2]. It is characterized by symmetrical proximal weakness; although,
extraocular muscles are typically spared, there are a few case reports
of associated external ophthalmoplegia [3,4] and one case report with
optic atrophy [5]. We report a boy with SMA type 1 with optic atrophy
due to isolated deletion of exon 8 of the SMN gene.
A preterm, 34 week, male baby, with birthweight of
1700 g was born to a 24 year-old para 2 live 1 mother, by third degree
consanguineous marriage. Baby was delivered by vaginal route, with
delayed cry at birth, was born limp and apneic requiring positive
pressure ventilation and chest compression. Mother had history of
polyhydramnios with amniotic fluid index (AFI) of 29 cm in second
trimester with decreased fetal movements. There was a history of sibling
death of a male baby at 30 weeks of gestation born one and half years
back. On examination, baby was alert with spontaneous eye opening, had
long facies with bilateral temporal hollowing; pupils were mid-dilated
and non-reacting to light. Tone was decreased in all limbs, power was
2/5 around hip joint and knee joint and 3/5 in bilateral elbow joints;
contractures were present at elbow, ankle and foot. Tongue
fasciculations were present and bilateral deep tendon reflexes were
absent. Baby had bulbar palsy with bilateral optic disk pallor.
Baby was continued on mechanical ventilation and IV
fluids and later was started on tube feeds. Baby had recurrent episodes
of gastroesophageal reflux (GER). Investigations revealed serum creatine
phosphokinase (total) of 150 IU/L, tandem mass pectrometry (TMS) and
urine gas chromatography ass pectrometry (GCMS) were normal. Muscle
biopsy showed maintained fascicular architecture with variation in fibre
size with focal fat infiltration and occasional muscle fiber
degeneration. No dystrophic, neurogenic, congenital myopathic, atrophic
changes were seen. Gene analysis for SMN1 gene revealed exon 8
deletion. Baby remained ventilated in hospital with multiple extubation
failures, and died on day 57 of life.
In SMA, there is homozygous mutation or deletion of
the survival motor neuron 1 (SMN1) gene, located in
the telomeric region of chromosome 5q13. SMN2, a gene that is
similar to SMN1 is located in the centromeric region, determines
the severity of illness [6]. Genetic alteration to the SMN1 gene
is responsible for a reduction in survival motor neuron (SMN) protein.
The SMN2 gene only produces 25% of SMN protein and so does not
completely compensate for the absence of SMN1 [6]. The lack of
the SMN protein causes degeneration of alpha motor neurons in the
ventral horn of the spinal cord.
According to the age of onset and clinical severity
SMA is divided into three subtypes (types 1-3). The hallmark of SMA type
1 is severe, progressive muscle weakness and hypotonia and present by 6
months of age, with 95% of patients having signs and symptoms by 3
months [5,6]. Optic atrophy is an unreported association of SMA, with
the exception of one case report [5]. Present case had history of
product of consanguineous marriage with previous sibling death with
similar features, with antenatal ultrasound suggestive of polyhydramnios,
with typical presentation of SMA and atypical presentation of
extraocular muscle involvement with optic atrophy.
In conclusion, isolated exon 8 deletion of the SMN
gene is a rarely reported and unusual mutation of SMA and optic atrophy
is an unreported association.
REFERENCES
1. Bogari NM, Bogari FR, Rayes HH, Alqassimi NM,
Balto HM, Dannoun A, et al. Molecular Genetic Diagnosis for a
family with type 1 spinal muscular atrophy (SMA) via analysis of the
survival motor neuron (SMN) gene. J Rare Dis Diagn Ther. 2015;1:21.
2. Gambardella A, Mazzei R, Toscano A, Annesi G,
Pasqua A, Annesi F, et al. Spinal muscular atrophy due to an
isolated deletion of exon 8 of the telomeric survival motor neuron gene.
Ann Neurol. 1998;5:836-9
3. Pachter BR, Pearson J, Davidowitz J, Reuben R,
Boal D, Carr R, et al. Congenital total external ophthalmoplegia
associated with infantile spinal muscular atrophy. Fine structure of
extraocular muscle. Invest Ophthalmol. 1976;15:320-4.
4. Dubrovsky A, Taratuto AL, Martino R. Distal spinal
muscular atrophy and ophthalmoparesis: A case with selec-tive type 2
fiber hypotrophy. Arch Neurol. 1981;38:594-6.
5. Maiti D, Bhattacharya M, Yadav S. Isolated exon 8
deletion in type 1 spinal muscular atrophy with bilateral optic atrophy:
Unusual genetic mutation leading to unusual manifestation? J
Postgraduate Med. 2012,58;4:294-5.
6. Baioni MTC, Ambiel CR. Spinal muscular atrophy: Diagnosis,
treatment and future prospects. Jornal de Pediatria. 2010;86:261-9.
|
|
 |
|